Are rare cancer survivors at elevated risk of subsequent new cancers?

ABSTRACT:

Background

Although rare cancers account for 27% of cancer diagnoses in the US, there is insufficient research on survivorship issues in these patients. An important issue cancer survivors face is an elevated risk of being diagnosed with new primary cancers. The primary aim of this analysis was to assess whether a history of rare cancer increases the risk of subsequent cancer compared to survivors of common cancers.

Methods

This was a prospective cohort study of 16,630 adults with personal and/or family history of cancer who were recruited from cancer clinics at 14 geographically dispersed US academic centers of the NIH-sponsored Cancer Genetics Network (CGN). Participants' self-reported cancer histories were collected at registration to the CGN and updated annually during f

SUBMITTER: Finkelstein DM 

PROVIDER: S-EPMC6385466 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature